Commentary
Published in:
Volume 5 / Year 2016 / Issue 1
Volume 5 / Year 2016 / Issue 1
Abstract: The importance of obtaining IRB/EC consent for waiver of consent before embarking on retrospective chart review studies was highlighted using the recent case of a manuscript submitted to GaBI… Read More »
Low-cost generic drug programs in the US: implications for payers and researchers
Page: 6-7
Abstract: Low-cost generic drug programs (LCGPs) provide affordable generics in the US. However, LCGPs have implications for managed care organizations and researchers relying on claims data. Submitted: 7 March 2016;… Read More »